Journal Article Research Support, Non-U.S. Gov't Epublish 15 citations
PubMed: 34728715 DOI: 10.1038/s41598-021-00958-4
Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Sci Rep 11(1):21533
Authors: Keiko Morotomi-Yano, Ken-Ichi Yano
Affiliations
- Institute of Industrial Nanomaterials, Kumamoto University, Kumamoto, Japan.
- Institute of Industrial Nanomaterials, Kumamoto University, Kumamoto, Japan.
Abstract
DNA topoisomerase II (TOP2) is a nuclear protein that resolves DNA topological problems and plays critical roles in multiple nuclear processes. Human cells have two TOP2 proteins, TOP2A and TOP2B, that are localized in both the nucleoplasm and nucleolus. Previously, ATP depletion was shown to augment the nucleolar localization of TOP2B, but the molecular details of subnuclear distributions, particularly of TOP2A, remained to be fully elucidated in relation to the status of cellular ATP. Here, we analyzed the nuclear dynamics of human TOP2A and TOP2B in ATP-depleted cells. Both proteins rapidly translocated from the nucleoplasm to the nucleolus in response to ATP depletion. FRAP analysis demonstrated that they were highly mobile in the nucleoplasm and nucleolus. The nucleolar retention of both proteins was sensitive to the RNA polymerase I inhibitor BMH-21, and the TOP2 proteins in the nucleolus were immediately dispersed into the nucleoplasm by BMH-21. Under ATP-depleted conditions, the TOP2 poison etoposide was less effective, indicating the therapeutic relevance of TOP2 subnuclear distributions. These results give novel insights into the subnuclear dynamics of TOP2 in relation to cellular ATP levels and also provide discussions about its possible mechanisms and biological significance.
MeSH
Dna Topoisomerases, Type I, Cells, Dna Topoisomerases, Type Ii, Rna Polymerase I, Dna-Directed Rna Polymerases
Cited by
- The human RNA polymerase I structure reveals an HMG-like docking domain specific to metazoans. Life Sci Alliance, 2022
- The nucleolar shell provides anchoring sites for DNA untwisting. Commun Biol, 2024
- A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents. Int J Mol Sci, 2023
- CRAMP1-dependent histone H1 biogenesis is essential for topoisomerase II inhibitor tolerance. Mol Cell, 2025
- The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment. J Transl Med, 2025
- Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ. Sci Rep, 2022
- Untangling the roles of TOP2A and TOP2B in transcription and cancer. Sci Adv, 2022
- Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level. Nucleic Acids Res, 2023